DUBLIN--(BUSINESS WIRE)--The "Peptic Ulcers - Pipeline Insight, 2018" drug pipelines has been added to ResearchAndMarkets.com's offering.
'Peptic Ulcers - Pipeline Insight, 2018' report offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Peptic Ulcers development.
The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type.
Pipeline therapeutics development coverage provides descriptive product profiles including (but not limited to) drug description, product development and R&D activities encompassing clinical and pre-clinical studies, designations, collaborations, licensing deals, grants, technologies and patent details.
Key Topics Covered:
1. Report Introduction
2. Peptic Ulcers Overview
3. Pipeline Therapeutics
- An Overview of Pipeline Products for Peptic Ulcers
4. Comparative Analysis
5. Products in Clinical Stage
- Product Description
- Research and Development
- Product Development Activities
6. Products in Pre-Clinical and Discovery Stage
- Product Description
- Research and Development
- Product Development Activities
7. Therapeutic Assessment
- Assessment by Route of Administration
- Assessment by Stage and Route of Administration
- Assessment by Molecule Type
- Assessment by Stage and Molecule Type
8. Inactive Products
- Product Description
- Research and Development
-
Product Development Activities
Companies Mentioned
- Astellas Pharma Inc
- Boryung Pharmaceutical Co Ltd
- ChoDang Pharm Co Ltd
- Daewoong Pharmaceutical Co Ltd
- Kukje Pharmaceutical Industry Co Ltd
- RaQualia Pharma Inc
- Sequella Inc
- Sinil Pharmaceutical Co Ltd
For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/g9zprb/peptic_ulcers?w=4
